These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C? Ahmed MS; Wong CF J Nephrol; 2007; 20(3):350-6. PubMed ID: 17557269 [TBL] [Abstract][Full Text] [Related]
4. Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. Fabrizi F; Lunghi G; Messa P; Martin P J Nephrol; 2008; 21(6):813-25. PubMed ID: 19034865 [TBL] [Abstract][Full Text] [Related]
5. Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia. Korte MR; van Heerde MJ; de Man RA; Betjes MH Neth J Med; 2008 Jan; 66(1):27-30. PubMed ID: 18219065 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease. Fabrizi F; Plaisier E; Saadoun D; Martin P; Messa P; Cacoub P Am J Kidney Dis; 2013 Apr; 61(4):623-37. PubMed ID: 23102733 [TBL] [Abstract][Full Text] [Related]
12. [Membranoproliferative glomerulonephritis in patients with cryoglobulinemia complicating hepatitis C virus: report of 11 cases]. Ben Fatma L; Ben Hamida F; Aoudia R; Goucha R; Kaaroud H; Béji S; Barbouch S; Hedri H; Abderrahim E; Elyounsi F; Ben Abdallah T; Ben Moussa F; Kheder A Tunis Med; 2007 Mar; 85(3):220-4. PubMed ID: 17668578 [TBL] [Abstract][Full Text] [Related]
13. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Quartuccio L; Soardo G; Romano G; Zaja F; Scott CA; De Marchi G; Fabris M; Ferraccioli G; De Vita S Rheumatology (Oxford); 2006 Jul; 45(7):842-6. PubMed ID: 16418196 [TBL] [Abstract][Full Text] [Related]
14. Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Roccatello D; Fornasieri A; Giachino O; Rossi D; Beltrame A; Banfi G; Confalonieri R; Tarantino A; Pasquali S; Amoroso A; Savoldi S; Colombo V; Manno C; Ponzetto A; Moriconi L; Pani A; Rustichelli R; Di Belgiojoso GB; Comotti C; Quarenghi MI Am J Kidney Dis; 2007 Jan; 49(1):69-82. PubMed ID: 17185147 [TBL] [Abstract][Full Text] [Related]
15. [Monoclonal antibodies to B-lymphocytes (rituximab) in the treatment of HCV-associated severe cryoglobulinemic glomerulonephritis]. Milovanova SIu; Lopatkina TN; Kozlovskaia LV; Krasnova TN Ter Arkh; 2007; 79(6):69-72. PubMed ID: 17684972 [No Abstract] [Full Text] [Related]
16. Treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia--anti-viral therapy vs rituximab. Bruchfeld A; Saadoun D; Cacoub P Rheumatology (Oxford); 2006 Jun; 45(6):783-4; author reply 784-5. PubMed ID: 16679341 [No Abstract] [Full Text] [Related]
17. [Treatment of post-transplant glomerulonephritis]. Sandrini S; Valerio F G Ital Nefrol; 2008; 25 Suppl 44():99-106. PubMed ID: 19048593 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus associated glomerulopathies. Ozkok A; Yildiz A World J Gastroenterol; 2014 Jun; 20(24):7544-54. PubMed ID: 24976695 [TBL] [Abstract][Full Text] [Related]
19. Renal manifestations associated with hepatitis C virus. Sinico RA; Fornasieri A; D'Amico G Ann Med Interne (Paris); 2000 Feb; 151(1):41-5. PubMed ID: 10761561 [TBL] [Abstract][Full Text] [Related]
20. [Interferon therapy in cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection]. Mátyus J; Kovács J; Ujhelyi L; Kárpáti I; Dalmi L; Kakuk G Orv Hetil; 1996 Nov; 137(45):2527-30. PubMed ID: 8999399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]